Utah Medical Products (UTMD) EV to CFO (2010 - 2026)

Utah Medical Products has reported EV to CFO for 17 years, with the latest figure at 95.47 in Q2 2026.

• On a quarterly basis, EV to CFO rose 171.9% year-over-year to 95.47 in Q2 2026; TTM through Jun 2026 was 11.15, a 56.11% increase from a year earlier, with the FY2025 full-year figure at 6.3, down 23.45% from the prior year.
• EV to CFO was 95.47 for Q2 2026 at Utah Medical Products, up from 35.37 in the prior quarter.
• The five-year high for EV to CFO was 95.47 in Q2 2026, with the low at 22.52 in Q1 2025.
• Average EV to CFO over 5 years is 43.14, with a median of 40.72 recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: EV to CFO tumbled 35.95% in 2025, then jumped 171.9% in 2026.
• Over 5 years, EV to CFO stood at 51.0 in 2022, then decreased by 21.79% to 39.89 in 2023, then grew by 4.16% to 41.55 in 2024, then tumbled by 35.95% to 26.61 in 2025, then jumped by 258.74% to 95.47 in 2026.
• The last three EV to CFO figures came in at 95.47 (Q2 2026), 35.37 (Q1 2026), and 26.61 (Q4 2025), per Business Quant data.